药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Enprofylline
Guselkumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Guselkumab.
Enprofylline
Sirukumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Sirukumab.
Enprofylline
Brodalumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Brodalumab.
Enprofylline
Sarilumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Sarilumab.
Enprofylline
Peficitinib
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Peficitinib.
Enprofylline
Voclosporin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Voclosporin.
Enprofylline
Pirarubicin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Pirarubicin.
Enprofylline
Ravulizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ravulizumab.
Enprofylline
Ixekizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ixekizumab.
Enprofylline
Melengestrol
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Melengestrol.
Enprofylline
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone isonicotinate.
Enprofylline
Tepoxalin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tepoxalin.
Enprofylline
Meprednisone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Meprednisone.
Enprofylline
Fluprednisolone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluprednisolone.
Enprofylline
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Antilymphocyte immunoglobulin (horse).
Enprofylline
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Peginterferon beta-1a.
Enprofylline
Tixocortol
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tixocortol.
Enprofylline
Vilanterol
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vilanterol.
Enprofylline
Dinutuximab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dinutuximab.
Enprofylline
Blinatumomab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Blinatumomab.